National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Small
Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) experts are
coming to Oklahoma City to conduct an SBIR Outreach Event.
Wednesday, September 25th from 9:00 am to 4:00 pm at the OUHSC PHF Conference Center. See the
attached document for additional information. https://research.ouhsc.edu/Portals/1329/Assets/Documents/OCAST_NIH_SBIR.docx?ver=2019-09-09-084407-903
DEADLINE EXTENDED: OSCTR TPIR Trainee Program
Seeking applicants for the sixth year of the research training program Translating Practice into
Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic
Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal
of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to
translate their clinical observations and ideas for improving practice into practical and feasible research
projects. Attached is a detailed description and application due September 13, 2019.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/OSCTR TPIR information 2019.pdf?ver=2019-08-12-083211-813
Office of Technology Development presents a third opportunity to engage with industry
(for more information go to http://www.ou.edu/otd/ICO, or email firstname.lastname@example.org for specific submission details):
Almirall is looking to sponsor academic research for target identification, validation, and/or to advance pre-clinical
therapeutic opportunities into clinical settings for “novel targets, pathways, or therapeutic candidates relating to
chronic immune-inflammatory disease” (expiration 9/30/19). Funding up to $250K per project to be awarded by
Almirall in November 2019.
Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS
The abstract submission deadline for the HHDC 2019 Research Symposium is Friday, October 4th. Abstracts
must be received by 5 p.m. HHDC 2019 Research Symposium will be held on Friday, November 15, 2019 at the
Samis Education Center in Children’s Hospital in Oklahoma City. The Symposium will consist of selected oral
presentations, a poster session, and Symposia talks by P. Darrell Neufer, PhD, Professor, East Carolina University,
Matthew Rodeheffer PhD, Associate Professor, Yale University and Scott Summers, PhD, Professor and Chair,
The University of Utah. For abstract submission guidelines and to RSVP for this free event, please go to:
https://hammdiabetescenter.org/Research/Symposium Please contact Katie-Hoefling@ouhsc.edu with any
questions for this event.
IMPORTANT NIH INFORMATION: ORCID Number – an ORCID Number is required of all Individuals Supported
by Research Training, Fellowship, Research Education, and Career Development Awards Beginning in FY 2020.
This requirement will go into effect October 1, 2020. For the specific Notice and instructions on how to get your
assigned ORCID Number please go to: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-109.html
The University of Oklahoma Center on Native Health Center of Biomedical Research Excellence (COBRE)
on the Norman campus is requesting preproposals to advance inquiry into the social and behavioral determinants of the health
of American Indian people in Oklahoma. Interested candidates should submit a one-page overview (including specific aims)
of their proposed research as a PDF file to Paul Spicer (email@example.com) no later than September 15, 2019.
Project budgets generally will not exceed $150,000 in direct costs for each year.
For additional information refer to the attached document.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/OUCNH Call for Proposals 190821.docx?ver=2019-08-26-082925-747
Save the Date – ORA Noon Conference
Navigating the ORA Proposal Submission Process
Speaker(s): Lisa Asch and Valorie Owens, Office of Research Administration
Offered: September 25, 2019 LIB-299 12-1pm
Overview: This session will cover the basics of proposal preparation and map out the process of submission through
the Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for during the
pre-award review, such as budget considerations, eligibility, and compliance with applicable rules and policies. We will also
cover topics related to proposal submission, such as grant routing forms and the systems used to submit federal grants.
The overall goal of this presentation is to provide a basic understanding of and advice on proposal preparation and submission
Notice of Changes to NIDCR's Clinical Terms of Award (CToA) Policy (NOT-DE-19-008)
Report on Reducing Administrative Burden for Researchers: Animal Care and Use in Research
Sexual and Gender Minority Populations in NIH-Supported Research (NOT-OD-19-139)
Notice of Change of NIA Intent to Fund Awards for RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)" (NOT-AG-19-041)
Notice of NIAMS Withdrawal from Participation in PAR-19-333 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance
and Late Stage Development (SB1, R44) Clinical Trial Not Allowed"(NOT-AR-20-004)
Notice of NCCIH's Participation in PA-19-196 "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to
Promote Diversity in Health-Related Research (Parent F31)
Notice of Clarification to Eligibility Information in PAR-19-349 "NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)" (NOT-CA-19-069)
Correction to RFA-CA-19-045 "Participant Engagement and Cancer Genome Sequencing (PE-CGS) (U2C Clinical Trial Optional)" (NOT-CA-19-070)
Notice of Correction to Key Dates for PAR-19-345 " NIDA Program Project Grant Applications (P01 Clinical Trial Optional)" (NOT-DA-19-071)
Notice to Extend the Expiration Date for PAR-18-205 "NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)" (NOT-EB-19-019)
Notice of Expiration of RFA-HL-19-014 Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart,
Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed) (NOT-HL-19-718)
Notice of NIMHD Withdrawal from Participation in PA-19-052, "NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) (NOT-MD-20-002)
Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program (NOT-TW-19-007)
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse (NOT-DA-19-066)
Notice of Special Interest in X-ray-based Devices for Trauma Care(NOT-EB-19-015)
Notice of Special Interest in Ultrasound and Optics-based Devices for Trauma Care (NOT-EB-19-016)
Notice of Special Interest in Radiation Monitoring for Trauma Care (NOT-EB-19-017)
Notice of Special Interest in Physiological Monitoring and Point of Care Technologies for Trauma Care
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) (PAR-19-352)
Deadline October 17, 2019 and February 5, 2020.
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) (PAR-19-353) – Deadline October 21, 2019 and May 27, 2020
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) (PAR-19-354) – Deadline October 21, 2019 and May 27, 2020
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) (PAR-19-355)
Deadline October 16, 2019
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
(PAR-19-356) - Deadline October 18, 2019 and February 20, 2020
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
(PAR-19-358) - Deadline October 16, 2019
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)
(PAR-19-359) - Deadline October 16, 2019.
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
(PAR-19-360) - Deadline October 17, 2019 and February 5, 2020.
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) (PAR-19-361)
Deadline November 12, 2019 and March 11, 2020
Food as Medicine: Food Insecurity and HIV-related Comorbidities, Coinfections, and Complications within the Mission of the NIDDK
(R01 Clinical Trial Optional) (RFA-DK-19-019) – Deadline March 9, 2020
The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed) (RFA-NS-19-038)
Deadline October 22, 2019
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (U24 - Clinical Trial Required -Infrastructure)
(RFA-OD-19-025) – Deadline December 2, 2019
Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (UG1 Clinical Trial Required)
(RFA-OD-19-026) – Deadline December 2, 2019
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma
(UM1 Clinical Trial Optional) (RFA-RM-19-013) – Deadline November 26, 2019.
Pfizer – Global Medical Grants – Deadline October 15, 2019
Melanoma Research Alliance – Proposals for Preclinical, Translational and Early Clinical Research
Deadline October 7, 2019